e read the article by Koyuncu et al. with interest and since we have had experience on the subject because of a long time follow up of a similar case, we wanted to present our opinion, also to contribute and underline some different points about Postpartum Plasmapheresis Treatment in HELLP syndrome.
1
A 28-year-old G1P1 was admitted to our clinic at 36 weeks of gestation. The blood pressure (BP) value was 141/90 mmHg, her platelet counts were 72*10. e3/mikroL, in the biochemical examination; AST: 273 U/L, ALT: 286 U/L, GGT: 74 U/L, LDH: 551 U/L, CK: 194 U/L, d-dimer: 3.34 mg/L and protein was 2 positive in spot urine, preeclampsia was diagnosed an emergency caesarean section was done (Table 1) . Magnesium infusion and antihypertensive treatment were started. Plasmapheresis treatment was planned after the surgery due to 10-12 schistocytes were observed in all areas in the peripheral blood smear. 17 units of fresh frozen plasma (FFP) were used during plasmapheresis. During the follow-up period in the intensive care unit, platelet values started to increase from day 3, and AST, ALT, LDH, total bilirubin, urea and creatinine values started to return to normal on the 3 rd day (Table 1) . On the 5 th day after the plasmapheresis treatment, patients all vital signs and laboratory values returned to normal and she was discharged.
Plasmapheresis treatment is an alternative treatment that can be used in HELLP syndrome. It is based on removal of antibodies, immune complexes and some toxins from plasma. Although the mechanism of action of plasmapheresis in HELLP syndrome is not fully known, it is stated that in patients with resistant HELLP syndrome and with organ failure, it increases platelet count and improves renal function. 2 Plasma exchange is estimated to eliminate aggregate and procoagulant factors discharged from endothelial cells and active platelets. 2 There are no definitive statements about the indications, time and frequency of plasmapheresis in the literature. When limited number of studies are examined, postpartum 24- 72 hours, it has been suggested to patients with platelet values below 100 * 10 e3/microL. However it is not clear when it should be terminated, it is stated in a study that when platelets start to rise and the platelet count is 100 * 10.e3/microL it can be terminated. 2 We performed plasmapheresis at postpartum 12 th hour. We did not need to recur because the platelet values increased above 100 * 10e3/microL at 30 th hour of plasmapheresis.
The pathophysiology and treatment of preeclampsia and HELLP syndrome are highly controversial for obstetricians. 3 Plasmapheresis, which is an alternative treatment modality in HELLP syndrome, needs multidisciplinary approach such as; anesthesiologist, obstetrician, hematologist, blood banking and many equipment requiring, therefore is a difficult prosess. However, it is an alternative and life-saving treatment modality for the treatment of HELLP syndrome if it is administered with the right timing in right selected cases.
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